Clinical Trials · NCT02059564
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Recruitment status
- Unknown
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Enrollment
- 44
- Start date
- Dec 2013
- Locations
- 1 site, United States
- Primary endpoint
- PK profile of acetaminophen